Jordan Morningstar

SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms

Soravis Osataphan, Chiara Macchi, Garima Singhal et al. · JCI Insight · 2019 · 212 citations · Full text

Metabolic Remodeling, Glucose Tolerance, Insulin Signaling +25

Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease

Curtis R. Warren, John O’Sullivan, Max Friesen et al. · Cell stem cell · 2017 · 192 citations · Full text

Genome-wide Association Study, Induced Pluripotent Stem Cell, Functional Genomics +10

Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes

John O’Sullivan, Jordan Morningstar, Qiong Yang et al. · Journal of Clinical Investigation · 2017 · 144 citations · Full text

Unidentified Peaks, Metabolic Disorder, Cardiometabolic Risk +23

Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk

Debby Ngo, Mark D. Benson, Jonathan Z. Long et al. · JCI Insight · 2021 · 78 citations · Full text

Genetics, Immunology, Genetic Epidemiology +19

Induction of metabolic quiescence defines the transitional to follicular B cell switch

Jocelyn R. Farmer, Hugues Allard‐Chamard, Na Sun et al. · Science Signaling · 2019 · 58 citations · Full text